ACN
56
-3
AME
63
-2
ADP
61
-3
D
43
-2
EFX
47
4
ES
45
5
CVS
44
4
ESS
39
-5
ADSK
66
10
A
48
-3
CCI
36
2
AIZ
52
2
CI
42
-3
DVA
47
-3
EL
52
-10
ADM
48
-3
CRM
57
7
AVGO
26
-2
BBY
41
-9
CPB
37
-2
ACN
56
-3
AME
63
-2
ADP
61
-3
D
43
-2
EFX
47
4
ES
45
5
CVS
44
4
ESS
39
-5
ADSK
66
10
A
48
-3
CCI
36
2
AIZ
52
2
CI
42
-3
DVA
47
-3
EL
52
-10
ADM
48
-3
CRM
57
7
AVGO
26
-2
BBY
41
-9
CPB
37
-2
Financhill
Back

Mirum Pharmaceuticals, Inc. 10K Form

Buy
62

MIRM
Mirum Pharmaceuticals, Inc.

Last Price:
$71.57
Seasonality Move:
25.4%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MIRM News And Ratings

See the #1 stock for the next 7 days that we like better than MIRM

MIRM Financial Statistics

Sales & Book Value

Annual Sales: $336.9M
Cash Flow: $39.5M
Price / Cash Flow: 82.19
Annual Sales: $5.69
Price / Book: 12.59

Profitability

EPS (TTM): -0.86180
Net Income (TTM): $-41.4M
Gross Margin: $254.7M
Return on Equity: -16.73%
Return on Assets: -5.85%

Mirum Pharmaceuticals, Inc. Earnings Forecast

Key Mirum Pharmaceuticals, Inc. Financial Ratios

  • The Gross Profit Margin over the past 7 years for MIRM is 75.61%.
  • The Selling, General & Administrative Expenses for MIRM have been equal to 60.03% of Gross Profit Margin.
  • The Research & Development expenses have been 41.59% of Revenue.
  • The Net Earning history of MIRM is -26.10% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 3 years.

Mirum Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MIRM
CUSIP: 604749
Website: mirumpharma.com

Debt

Debt-to-Equity Ratio: 1.09
Current Ratio: 3.31
Quick Ratio: 3.01

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 189.66

MIRM Technical Analysis vs Fundamental Analysis

Buy
62
Mirum Pharmaceuticals, Inc. (MIRM) is a Buy

Is Mirum Pharmaceuticals, Inc. a Buy or a Sell?